In: Commentaries
Commentary: What if …
December 23, 2024Several years ago we discussed potential scenarios related to the outcome of Cassava’s Phase 3 program. To remind our readers, concerns…
Read MoreIntentional misconduct or too busy to oversee the lab?
December 23, 2024The recent scientific misconduct in the laboratories of Eliezer Masliah is not the first such case and will unfortunately most likely…
Read MoreImagine…
December 23, 2024… you go to a supermarket or a grocery store, buy everything you need, pay at the cashier’s but leave all…
Read MoreDon’t throw the baby out with the bathwater
December 22, 2023The pressure to replace animal research with non-animal methods is growing. Earlier this year, NIH has issued a “Request for Information…
Read More“Home inspections” for life sciences companies going public before clinical proof of concept
December 22, 2023For over a decade, there is a trend of less specialized investment firms and public equity investors betting on life sciences…
Read More“Publication of negative/null results discussed at NIH”
November 2, 2022NINDS Office of Research Quality has presented a proposal on how to address the publication bias. It can be watched HERE (starts at…
Read More“The customer is king!”
November 2, 2022Once during our vacation in Greece, our children asked for ice cream after having dinner. When the waiter was asked about…
Read More“Hold your horses!”
November 2, 2022Risk of Alzheimer’s disease nearly doubles in older adults with Covid-19! Like many of you, several weeks ago we have also…
Read More“The Steal syndrome – or the FDA Modernization Act to end animal testing requirement passes U.S. Senate”
November 2, 2022On September 29, 2022, the U.S. Senate passed the FDA Modernization Act 2.0, S.5002, by unanimous consent. While it is unclear…
Read MoreArchimedes‘ fulcrum and the “reproducibility” debate
June 16, 2022We like to cite Dorothy Bishop who wrote several years ago: “We know how to formulate and test hypotheses in controlled…
Read More